Results 41 to 50 of about 61,036 (213)
Imipenem Heteroresistance in Nontypeable Haemophilus influenzae [PDF]
In the post-vaccine era, the nontypeable (i.e. nonencapsulated) Haemophilus influenzae (NTHi) revealed as an opportunistic pathogen causing and exacerbating multiple upper and lower respiratory tract diseases.
Cherkaoui, Abdessalam
core +1 more source
This paper highlights a concerning scenario of environmental contamination by multidrug‐resistant bacteria, underscoring the need for integrated surveillance and control strategies to address antimicrobial resistance in aquatic environments within the context of One Health.
Francisco Lucas de Amorim Nascimento +13 more
wiley +1 more source
Drug utilization evaluation of imipenem and intravenous ciprofloxacin in a teaching hospital [PDF]
Drug Utilization Evaluation (DUE) studies are designed to assess drug usage appropriateness. We aim to evaluate the drug utilization of intravenous ciprofloxacin and imipenem, two of the broad spectrum antibiotics that consume a significant proportion of
Ziaie, Shadi +5 more
core
A novel gene linked to Imipenem resistance in E. coli isolate lacking known Imipenem-resistance genes [PDF]
Imipenem-resistant Escherichia coli strains represent a growing public health concern, posing a threat due to their resistance to last-resort antibiotics. Here, we present the discovery of the Imipenem-Linked Resistance Gene VIN (ILR-VIN) within E.
Thang Quang Truong +16 more
core +1 more source
Impaired imipenem uptake associated with alterations in outer membrane proteins and lipopolysaccharides in imipenem-resistant Shigella dysenteriae [PDF]
Three imipenem-resistant mutants were obtained from a clinical isolate (C152) of Shigella dysenteriae by selection with increasing concentrations of imipenem.
Kar, Alak Kanti +2 more
core +1 more source
ABSTRACT The Clinical and Laboratory Standards Institute M100 document serves as a cornerstone standard for clinical microbiology laboratories in China. Maintaining the scientific rigor of its predecessors, the 36th edition incorporates updated epidemiological cutoff values, pharmacokinetic/pharmacodynamic data, and clinical efficacy evidence to revise
Kanghong Xu, Qi Wang, Hui Wang
wiley +1 more source
Detection of AmpC beta-lactamase production by enterobacteria has been problematic. Contrary to ESBLs, no specific guidelines are available for detection and confirmation of AmpC production by clinical relevant microorganisms.
Vlademir Vicente Cantarelli +5 more
doaj +1 more source
In this study, we evaluate the performance of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) for rapid detection of carbapenemase activity in Enterobacterales in clinical microbiology laboratories during a ...
Eva Gato +27 more
doaj +1 more source
An integrative metagenomic framework combining sequence, structural, and functional inference reveals a phylogenetically diverse and structurally conserved repertoire of putative beta‐lactamases across Antarctic soil microbiomes, with predominance of class A and subclass B3 enzymes and limited but detectable associations with mobile genetic elements ...
José Coche‐Miranda +8 more
wiley +1 more source
Prevalency of imipenem-resistant bacterial strains isolated from hospital and accuracy of Iranian imipenem disc product [PDF]
Background and Objective: Bacterial resistance to Imipenem is increased in bacterial infections in Iran. In regard to the importance of Imipenem in the treatment of nosocomial infections and the key role of disc diffusion method as a major antibiotic ...
Imani Fooladi AA +2 more
core

